Getinge Acquires Verrix
November 12, 2021
Getinge has acquired Verrix LLC, a San Clemente, California-based medical device company developing sterility assurance and infection-control technologies. Outcome Capital served as exclusive strategic and financial advisor to Verrix; Getinge said the acquisition secures its entry into the hospital sterility monitoring segment and expands its infection-control product offering.
- Buyers
- Getinge
- Targets
- Verrix
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Getinge Acquires Paragonix Technologies
August 22, 2024
Medical Devices
Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.
-
Medix Biochemica Acquires ViroStat LLC
November 10, 2023
Biotechnology
Medix Biochemica has acquired 100% of ViroStat LLC, a US-based manufacturer of infectious disease antibodies and antigens, expanding Medix's IVD raw materials portfolio and scientific capabilities. ViroStat will continue operating in Westbrook, Maine, and its employees and leadership (including President Dr. Douglas McAllister and General Manager Duncan McAllister) will join Medix Biochemica.
-
Getinge Acquires Healthmark Industries Co. Inc.
October 11, 2023
Medical Devices
Getinge (Gothenburg, Sweden) has acquired 100% of Healthmark Industries Co. Inc. (Fraser, Michigan, USA) for approximately USD 320 million, a deal that closed following the HSR waiting period. Healthmark, a maker of instrument-care and infection-control consumables with ~400 employees and expected FY2023 net sales of about USD 126 million, will complement Getinge’s sterile reprocessing equipment, consumables and software and accelerate Healthmark’s international expansion.
-
Veranex Acquires Fusion Biotec
December 13, 2022
Medical Devices
Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.
-
Veranex Acquires Devicia, Clarvin and Affiliate Consultancies
October 11, 2022
Healthcare Services
Veranex, a global tech-enabled medtech service provider, acquired an ecosystem of Swedish medical device and IVD consultancies led by Devicia and Clarvin (including affiliates Kickfile, Lea Reg, and Limulus Bio). The add-on expands Veranex's regulatory, clinical, quality assurance, and biocompatibility capabilities and strengthens its European and UK presence to support MDR/IVDR strategies and local representation.
-
Veeva Systems Acquires Crossix Solutions for $430 Million
November 1, 2019
Data & Analytics
Veeva Systems acquired Crossix Solutions for $430 million in a transaction announced September 26, 2019 and closed November 1, 2019. Crossix — a privacy-safe patient data and analytics provider headquartered in New York City — will operate as an independent business unit within Veeva, with Crossix CEO Asaf Evenhaim continuing to lead; certain Crossix employees received long-term equity retention grants valued at about $120 million.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.